Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients
Abstract Objective Fertility-sparing treatment of atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EC) patients has recently emerged important social health topic. This study is designed to explore the risk factors for time to complete remission (CR) of fertility-sparing treat...
Saved in:
Main Authors: | Yingqiao Ding (Author), Yuan Fan (Author), Xingchen Li (Author), Yiqin Wang (Author), Jianliu Wang (Author), Li Tian (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia
by: Yuan Fan, et al.
Published: (2021) -
Characteristics of molecular classification in 52 endometrial cancer and atypical hyperplasia patients receiving fertility-sparing treatment
by: Yiqin Wang, et al.
Published: (2023) -
Significance of serum and pathological biomarkers in fertility-sparing treatment for endometrial cancer or atypical hyperplasia: a retrospective cohort study
by: Yiqin Wang, et al.
Published: (2021) -
Clinical features and outcome of 15 patients with recurrent endometrial cancer or atypical endometrial hyperplasia received primary fertility-sparing therapy followed by hysterectomy
by: Yuanting Li, et al.
Published: (2021) -
Pregnancy outcomes after fertility preservation in women with endometrial carcinoma and atypical endometrial hyperplasia: A systematic review and meta-analysis
by: Zerui Xiao, et al.
Published: (2021)